These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 429134)

  • 1. Retinyl acetate prophylaxis in cancer of the urinary bladder.
    Dawson WD; Miller WW; Liles WB
    Invest Urol; 1979 Mar; 16(5):376-7. PubMed ID: 429134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection from carcinogen-induced murine bladder carcinoma by interferons and an oral interferon-inducing pyrimidinone, bropirimine.
    Borden EC; Sidky YA; Ertürk E; Wierenga W; Bryan GT
    Cancer Res; 1990 Feb; 50(4):1071-4. PubMed ID: 2297754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of single dose N-methyl-N-nitrosourea on bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in rats.
    Grossman HB; Sonda LP; Lesser ML
    Invest Urol; 1981 May; 18(8):457-9. PubMed ID: 7228579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of L-tryptophan and sodium saccharin on urinary tract carcinogenesis initiated by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Fukushima S; Friedell GH; Jacobs JB; Cohen SM
    Cancer Res; 1981 Aug; 41(8):3100-3. PubMed ID: 7248968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of avitaminosis A and hypervitaminosis A on urinary bladder carcinogenicity of N-(4-(5-Nitro-2-furyl)-2-thiazolyl)formamide.
    Cohen SM; Wittenberg JF; Bryan GT
    Cancer Res; 1976 Jul; 36(7 PT 1):2334-9. PubMed ID: 1277139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats.
    Sakata T; Hasegawa R; Johansson SL; Zenser TV; Cohen SM
    Cancer Res; 1986 Aug; 46(8):3903-6. PubMed ID: 3731063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of L-tryptophan excess and vitamin B6 deficiency on rat urinary bladder cancer promotion.
    Birt DF; Julius AD; Hasegawa R; St John M; Cohen SM
    Cancer Res; 1987 Mar; 47(5):1244-50. PubMed ID: 3815336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced carcinogenesis by urinary tract infection in rats.
    Johansson SL; Anderström C; von Schultz L; Larsson P
    Cancer Res; 1987 Jan; 47(2):559-62. PubMed ID: 3539325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of N-[-4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer.
    Soloway MS; Martino C; Hyatt C; Marrone JC
    Natl Cancer Inst Monogr; 1978 Dec; (49):293-300. PubMed ID: 748783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing effect of allopurinol on the induction of bladder cancer in rats by n-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Wang CY; Hayashida S; Pamukcu AM; Bryan GT
    Cancer Res; 1976 May; 36(5):1551-5. PubMed ID: 1268818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aspirin on urinary bladder carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
    Cohen SM; Hasegawa R; Sakata T; Johansson SL
    Cancer Res; 1989 Jan; 49(2):372-7. PubMed ID: 2491954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sodium phenobarbital and sodium saccharin in AIN-76A diet on carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and N,N-dibutylnitrosamine in male F344 rats.
    Imaida K; Wang CY
    Cancer Res; 1986 Dec; 46(12 Pt 1):6160-4. PubMed ID: 3779637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epithelial bladder tumor induction in rats with N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide].
    Vlasov NN; Pliss GB; Balin VV
    Vopr Onkol; 1980; 26(3):63-7. PubMed ID: 7368659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
    Becci PJ; Thompson HJ; Grubbs CJ; Squire RA; Brown CC; Sporn MB; Moon RC
    Cancer Res; 1978 Dec; 38(12):4463-6. PubMed ID: 719631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of indomethacin on N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced urinary tract carcinogenesis.
    Holmäng S; Cano M; Grenabo L; Hedelin H; Johansson SL
    Carcinogenesis; 1995 Jul; 16(7):1493-8. PubMed ID: 7614682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neovascularization in rats during urinary bladder carcinogenesis induced by N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide.
    Cohen SM; Tatematsu M; Shinohara Y; Nakanishi K; Ito N
    J Natl Cancer Inst; 1980 Jul; 65(1):145-8. PubMed ID: 6930511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprevention by indomethacin of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder tumors.
    Grubbs CJ; Juliana MM; Eto I; Casebolt T; Whitaker LM; Canfield GJ; Manczak M; Steele VE; Kelloff GJ
    Anticancer Res; 1993; 13(1):33-6. PubMed ID: 8476227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early lesions in experimental bladder cancer: experimental design and light microscopic findings.
    Cohen SM; Jacobs JB; Arai M; Johansson S; Friedell GH
    Cancer Res; 1976 Jul; 36(7 PT 2):2508-11. PubMed ID: 1277158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A long-term study of reversible and progressive urinary bladder cancer lesions in rats fed N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Jacobs JB; Arai M; Cohen SM; Friedell GH
    Cancer Res; 1977 Aug; 37(8 Pt 2):2817-21. PubMed ID: 872108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.